Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Justyna Kozik-Jaromin"'
Autor:
Christian Lupinek, Kurt Derfler, Silvia Lee, Thomas Prikoszovich, Oliver Movadat, Eva Wollmann, Carolin Cornelius, Milena Weber, Renate Fröschl, Regina Selb, Katharina Blatt, Dubravka Smiljkovic, Volker Schoder, René Cervenka, Thomas Plaichner, Gottfried Stegfellner, Hans Huber, Rainer Henning, Justyna Kozik-Jaromin, Thomas Perkmann, Verena Niederberger, Ventzislav Petkov, Peter Valent, Adelheid Gauly, Hans Peter Leinenbach, Ingrid Uhlenbusch-Koerwer, Rudolf Valenta
Publikováno v:
EBioMedicine, Vol 17, Iss C, Pp 119-133 (2017)
Background: Prevention of IgE-binding to cellular IgE-receptors by anti-IgE (Omalizumab) is clinically effective in allergic asthma, but limited by IgE threshold-levels. To overcome this limitation, we developed a single-use IgE immunoadsorber column
Externí odkaz:
https://doaj.org/article/fc182c7678904540a33c121811dc1d3f
Autor:
Wolfgang Ramlow, Frido Himmelsbach, Franz Heigl, Justyna Kozik-Jaromin, Gerd Schmitz, Ingrid Uhlenbusch-Körwer, Jens Ringel, Frank Leistikow, Eberhard Röseler, Ralf Spitthöver, Rainer Heinzler, Nadim Abdul-Rahman, V.J.J. Schettler
Publikováno v:
Atherosclerosis Supplements. 30:225-231
Background Lipidapheresis was introduced for intractable hyperlipidemia as a more selective therapy than plasma exchange aiming to enhance efficacy and limit side-effects. Although this therapy is regarded safe, multicenter data from routine applicat
Autor:
Wolfgang Ramlow, Nadim Abdul-Rahman, Justyna Kozik-Jaromin, Jens Ringel, Frido Himmelsbach, V.J.J. Schettler, Ralf Spitthöver, Franz Heigl, Jenny Pham, Eberhard Röseler, Frank Leistikow, Rainer Heinzler, Gerd Schmitz
Publikováno v:
Atherosclerosis. Supplements. 30
Background Lipidapheresis techniques are increasingly used to treat drug-resistant hyperlipidemia but few efficacy studies under routine application are available. In this multicenter observational study we investigated direct adsorption of lipoprote
Autor:
Peter Heering, Olaf Loke, Dirk Meinke, Justyna Kozik-Jaromin, Jan Galle, Michael Schmitz, Klaus Kalb, Bernhard Fach, Peter Rawer
Publikováno v:
Nephrology Dialysis Transplantation. 31:1327-1334
Background Although citrate dialysate (CiDi) is regarded to be safe, dialysis modalities using higher dialysate volumes, like haemodiafiltration (HDF), may expose patients to higher citrate load and thus increase the risk of complications. We investi
Publikováno v:
Nephrology Dialysis Transplantation
Background Regional citrate anticoagulation is a very effective anticoagulation method for haemodialysis. However, it is not widely used, primarily due to the risk of hypocalcaemia. We studied citrate and calcium kinetics to better understand safety
Autor:
Thomas Plaichner, Kurt Derfler, Ingrid Uhlenbusch-Koerwer, Hans Huber, Silvia Lee, Eva Wollmann, Rudolf Valenta, Hans Peter Leinenbach, Rene Cervenka, Adelheid Gauly, Volker Schoder, Thomas Prikoszovich, Rainer Henning, Oliver Movadat, Justyna Kozik-Jaromin, Christian Lupinek, Gottfried Stegfellner, Ventzislav Petkov
Publikováno v:
5.3 Allergy and Immunology.
A novel highly selective single-use IgE-immunoadsorber, IgEnio, has been developed using BM10, a non-anaphylactic fragment of a monoclonal anti-human IgE antibody. In a proof of concept study, IgEnio was used to deplete IgE from the plasma of patient
Autor:
John F. Stover, E Helset, Julia Hasslacher, Harm Peters, Reto Stocker, T Henneberg, Stanislao Morgera, Michael Joannidis, H.-H. Neumayer, M Wehner, K Andersen, Torsten Slowinski, Detlef Kindgen-Milles, Justyna Kozik-Jaromin, S Brett
Publikováno v:
Critical Care
Regional citrate anticoagulation in continuous venovenous hemodialysis (citrate-CVVHD) has become a widely used technique in the ICU, which decreases risk of bleeding. However, concern exists about safety of citrate in liver failure patients. The aim
Autor:
John F. Stover, Kirsti Svendsen Andersson, Julia Hasslacher, Reto Stocker, Sarah Brett, Detlef Kindgen-Milles, Harm Peters, Torsten Slowinski, Justyna Kozik-Jaromin, Michael Joannidis, Thomas Henneberg, Stanislao Morgera, Markus Wehner, Elin Helset, Hans-H. Neumayer
Publikováno v:
Critical Care
Introduction Regional citrate anticoagulation (RCA) for continuous renal replacement therapy is widely used in intensive care units (ICUs). However, concern exists about the safety of citrate in patients with liver failure (LF). The aim of this study